Search Results 641-650 of 17189 for treatment resistant depression
... depression, and fatigue among patients with solid and liquid malignancies and using these data to increase the frequency of guideline-concordant care by: 1 ...
Age ≥ 18 years. · Must have RRMM after having received prior exposure to at least 3 prior lines of therapies in addition to being refractory to a Proteasome ...
Other studies have shown a link between the drug Metformin (the most widely used medication to treat prediabetes and type 2 diabetes) and a reduction in the ...
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
The purpose of this study is to assess the safety and tolerability of ONO-7475 monotherapy in patients with relapsed or refractory acute myeloid leukemia or ...
According to the Centers for Disease Control and Prevention, about 8 million adults in the U.S. are diagnosed with depression each year.
Clinical Trials · Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma · More about research at Mayo ...
Diagnosis & treatmentCare at Mayo Clinic ... New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant epilepsy ...
... treatment response with abiraterone acetate in metastatic castration-resistant prostate cancer. ... Care Therapy to Delay the Emergence of Resistant Bone ...
About this study. Recent reports have identified a specific oncogenic mutation L265P of the MYD88 gene in approximately 30% of the patients with the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.